DoctorChhavi Asthana

Postdoctoral Research Fellow - Multiple Sclerosis

Menzies Institute for Medical Research

  • Postdoctoral Research Fellow - Multiple Sclerosis
    Menzies Institute for Medical Research

FUNDED PROJECTS

  • GRANT
    Unravelling the interplay between EBV genomics and host T cell immune regulation in multiple sclerosis
    1 Jun 2023 - 31 May 2027
    People funded by this grant:
    • Zhou Y,
    • Smith C,
    • Taylor B,
    • Khanna R,
    • Liu J
    Project Total: $1,999,237; Epstein Barr Virus (EBV) infects most people in childhood. In some people, it leads to Multiple Sclerosis (MS) but we dont know who or why. This project will evaluate the genetics of people with MS and the EBV in their cells to determine which genetic variants predispose to MS risk and how the immune response varies. We aim to understand the relationship between EBV and human genomes and how it leads to MS to guide future diagnostic, therapeutic, and preventive strategies. Funded by: Medical Research Future Fund - Grant - Multiple Sclerosis Research ($2,549,568); University of Tasmania ($105,480).
  • CONSULTANCY/CONTRACT RESEARCH
    A Prospective Investigation of the Feasibility of Smartphone-Based Self-Monitoring to Characterise Cognitive and Neurological Impairment in Patients with Multiple Sclerosis (FLOODLIGHT MS-MOREACTIVE
    1 Jan 2022 - 31 Mar 2026
    People funded by this grant:
    • Taylor B,
    • Asthana C
    Project Total: $179,560; The MoreActive Floodlight MS study is a prospective investigation of the feasibility of smartphone based self-monitoring to characterise cognitive and neurological impairment in patients with multiple sclerosis. This study will help in answering the following key research questions: 1. Is there a correlation, both cross-sectional and longitudinal, between the Floodlight MS (FL MS) Cognitive Test digital outcome measures and established clinical and cognitive outcome assessments in patients with multiple sclerosis (pwMS), and can this be characterized into distinct trajectories? 2. Can the digital outcome measures collected with FL MS, MSReactor and Redenlab, together with clinical assessments, predict future disability or cognitive decline in pwMS? Funded by: Monash University ($179,560); University of Tasmania.